Diabetes technology

A register‐based study describing time trends in risk factor control and serious hypoglycaemia together with the effects of starting continuous glucose monitoring in people with type 1 diabetes in Norway

Diabet MedPublished Register-based study: repeated cross-sectional surveys and longitudinal cohort

Authors' conclusion

Between 2012 and 2020, we found marked improvements in glycaemic control and a considerable decrease in the proportion of individuals reporting serious hypoglycaemia. The proportion of individuals using CGM increased substantially and individuals that had started using CGM by 2020 showed greater improvement in glycaemic control and less serious hypoglycaemia.

Study context

Population
People with T1D in Norway, Norwegian Diabetes Register for Adults (NDR-A)cohort of 2057
Exposure
2020 vs 2012; started continuous glucose monitoring (CGM) 2013–2020 vs not started CGM
  • 2012n = 5,746reference
  • 2020n = 18,984
Outcome
Mean HbA1c (cross-sectional surveys)
Follow-up
2012 to 2020
Methodological detailstwo cross-sectional surveys (2012, 2020), real-world setting, Norwegian Diabetes Register for Adults (NDR-A)
  • Two cross-sectional surveys (2012, 2020)
  • Real-world setting
  • Norwegian Diabetes Register for Adults (NDR-A)

Main finding

As reported in the abstract

2012

66

mean · 99% CI 65–66 · mmol/mol (8.2%)

2020

61

mean · 99% CI 61–61 · mmol/mol (7.7%)

P < 0.0001

Observational data: associations, not effects.

Further findings

Outcome20122020Started CGMNot started CGMGreater improvement (mmol/mol (0.3%))P value
Proportion reporting serious hypoglycaemia (cross-sectional surveys) · 2012 to 20202020 vs 2012 · decreased16.9%6.2%— not stated in the abstract— not stated in the abstractP < 0.0001
Mean LDL-C (cross-sectional surveys) · 2012 to 20202020 vs 2012 · decreased · mmol/l2.80 (99% CI 2.78–2.83)2.63 (99% CI 2.61–2.65)— not stated in the abstract— not stated in the abstractP < 0.0001
Improvement in mean HbA1c (CGM cohort) · 2012 to 2020Started CGM vs Not started CGM · greater improvement with Started CGM3
Change in serious hypoglycaemia (CGM cohort) · 2012 to 2020— not stated in the abstract— not stated in the abstract−12.3%−6.2%

— not stated in the abstract

Mean blood pressure (cross-sectional surveys) · 2012 to 2020

Mean blood pressure increased slightly

Change in serious hypoglycaemia (CGM cohort) · 2012 to 2020

Greater reduction in serious hypoglycaemia with Started CGM

Original publication

A register‐based study describing time trends in risk factor control and serious hypoglycaemia together with the effects of starting continuous glucose monitoring in people with type 1 diabetes in Norway. Diabet Med. Published 25 April 2024. doi:10.1111/dme.15335

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.